Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Verve Therapeutics Inc VERV

Healthcare Biotechnology
Verve Therapeutics, Inc. is a clinical-stage genetic medicines company. The Company is focused on developing a new approach to the care of cardiovascular disease (CVD), transforming treatment from chronic management to single-course gene editing medicines. The Company’s lead programs include VERVE-101, VERVE-102, and VERVE-201, which target genes that have been validated as targets for lowering... see more

Recent & Breaking News (NDAQ:VERV)

Verve Therapeutics Announces Pipeline Progress and Reports Second Quarter 2024 Financial Results

GlobeNewswire August 8, 2024

Verve Therapeutics Inc Is Being Investigated By The Schall Law Firm, Which Urges Investors With Losses To Reach Out

Accesswire August 7, 2024

Verve Therapeutics Inc Is Under Investigation By The Schall Law Firm Which Encourages Investors With Losses To Make Contact

Accesswire August 6, 2024

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire August 2, 2024

Verve Therapeutics Inc Is Under Investigation By The Schall Law Firm Which Encourages Investors With Losses To Make Contact

Accesswire July 30, 2024

Verve Therapeutics Inc Is Under Investigation By The Schall Law Firm Which Encourages Investors With Losses To Make Contact

Accesswire July 29, 2024

Verve Therapeutics Inc Under Investigation By The Schall Law Firm Encourages Investors With Losses To Reach Out

Accesswire July 26, 2024

Verve Therapeutics Inc Under Investigation By The Schall Law Firm Encourages Investors With Losses To Reach Out

Accesswire July 25, 2024

Verve Therapeutics Inc Under Investigation By The Schall Law Firm Encourages Investors With Losses To Reach Out

Accesswire July 23, 2024

Verve Therapeutics Inc Under Investigation By The Schall Law Firm Encourages Investors With Losses To Reach Out

Accesswire July 22, 2024

Verve Therapeutics, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details- VERV

Accesswire July 22, 2024

Shareholders that lost money on Verve Therapeutics, Inc.(VERV) should contact Levi & Korsinsky about Securities Fraud Investigation - VERV

Accesswire July 19, 2024

Verve Therapeutics Incorporated Is Under Investigation By The Schall Law Firm And Investors With Losses Are Urged To Connect

Accesswire July 19, 2024

Verve Therapeutics, Inc. (VERV) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights

Accesswire July 18, 2024

The Schall Law Firm Is Investigating Verve Therapeutics Incorporated And Encourages Investors With Losses To Reach Out

Accesswire July 18, 2024

Shareholder Rights Advocates at Levi & Korsinsky Investigate Verve Therapeutics, Inc. (VERV) Regarding Possible Securities Fraud Violations

Accesswire July 17, 2024

The Schall Law Firm Is Conducting An Investigation Into Verve Therapeutics Inc And Encourages Investors Who Have Incurred Losses To Reach Out

Accesswire July 17, 2024

Levi & Korsinsky Reminds Shareholders of an Investigation into Verve Therapeutics, Inc. (VERV) Regarding Potential Securities Fraud Allegations

Accesswire July 17, 2024

Verve Therapeutics Inc Is Being Probed By The Schall Law Firm Urging Investors With Losses To Contact

Accesswire July 16, 2024

Did Verve Therapeutics, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate- VERV

Accesswire July 15, 2024